| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Biodel is a development-stage pharmaceutical company with a focus on drug reformulation technology. The company's VIAdel technology spurs faster onset of action from various drugs. The company's lead product VIAject works as a fast-acting insulin to treat diabetes. Also, the company has created an oral insulin in Phase I development.
| |